A Leading Startup in DC Immunotherapy (Biotech) from India is looking to raise funds
Posted By - Investment Banker
Posted date - 08/04/2021
BUSINESS BRIEF
Dendritic Cell (DC) based personalized immunotherapy product to provide an extended lease of life to stage IV Cancer patients. It is the first and only CDSCO approved company in India for DC Immunotherapy. It has received the Drug Controller General of India’s approval to treat Ovarian cancer, Colorectal cancer, Prostrate cancer and Non Small Cell Lung carcinoma.
Post marketing surveillance agreements with Medanta Gurgaon, Apollo Indraprastha New Delhi and Ruby Hall Pune. Agreements be signed soon with Tata Memorial Mumbai and Max Healthcare.
Cost Advantage: Immunotherapy products are sold in
US - $93,000
China - $30,000
Our Product - $8,500 (plus hospital charges).
Proposal
Capital Requirement
INR 75 Cr
Funding Status
I do not have any investment commitment
Horizontal Industry
Marketplace
Industry & Sub-Industry
Life Sciences (1)
Bio Technology, Life systems technologies
Technology/Product/Service Offering
Immunotherapy treatment for Cancer patients
StartUp Stage
Early Revenue
Business Segment Type
B2B, B2B2C
End use of fund (in %)
Financial Information |
2018 (in Cr) | 2019 (in Cr) | 2020 (in Cr) | 2021 (in Cr) |
|---|---|---|---|---|
Sales |
INR 1.429 Cr | INR 2.718 Cr | N.D | N.D |
EBITDA |
N.D | N.D | N.D | N.D |
PAT |
N.D | N.D | N.D | N.D |
TOTAL DEBT |
N.D | N.D | N.D | N.D |
Business Documents
Recommended Deals
An Electrical Machinery (Cables and wires) entity from India is looking to raise...
Sales (2019): INR 2.718 Cr
It is an established cables and wires manufacturing business based in Bangalore....
₹ 48 Cr
An Australia based cotton seed derivative (animal feed, oil) company with a pote...
Sales (2019): INR 2.718 Cr
The Company is an Australian cotton oil producer. It refines the cottonseed o...
₹ 60 Cr
A Hospitals and Healthcare (General Medical and Surgical Hospitals) entity from ...
Sales (2019): INR 2.718 Cr
It is a 30 bedded single speciality surgical hospital in Western Maharashtra asp...
₹ 20 Cr
A holistic healthcare platform from India is looking to raise strategic funding.
Sales (2019): INR 2.718 Cr
It is a holistic healthcare platform that strives to provide affordable healthca...
₹ 5 Cr
A Food processing entity from India is looking to raise strategic funding.
Sales (2019): INR 2.718 Cr
The Company is engaged in growing and processing of mushrooms and manufacturing ...
₹ 40 Cr
Premium
A Snack and Beverage Chain Offering Diverse Menu, Sustainability Efforts, and On...
Sales (2019): INR 2.718 Cr
It is a quick-service snack and beverage chain. It is ISO 22000 certified and ha...
₹ 20 Cr
A Market research Company from India is looking to raise strategic funding.
Sales (2019): INR 2.718 Cr
It is an established market research company with 7+ years of experience. It pro...
₹ 14 Cr
A Ready to cook food manufacturing Company from India is looking to raise fundin...
Sales (2019): INR 2.718 Cr
Founded in 2003, the company is an upward integrated, high-quality food products...
₹ 11.25 Cr
An Electronics manufacturing services entity from India is looking to raise stra...
Sales (2019): INR 2.718 Cr
The Company is engaged in the Electronics manufacturing services. It caters to v...
₹ 15 Cr
Premium
A Computer manufacturing entity from India is looking to raise strategic funding...
Sales (2019): INR 2.718 Cr
The Company is engaged in Designing, engineering & manufacturing capabilitie...
₹ 20 Cr
Premium
A Spice manufacturing company from India is looking to raise strategic funding.
Sales (2019): INR 2.718 Cr
It is a Spice Manufacturing Company. The company provides the regional tastes th...